Montelukast Sodium Tablets

Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast Sodium immediate release tablets in the strength of 10mg and Montelukast Sodium chewable tablets in 4mg & 5mg strengths, Ajanta Pharma said in a filing to BSE.

Unichem Laboratories gets USFDA approval, up 4.5%

Montelukast Sodium tablets 10mg are therapeutically equivalent to Singulair Tablets 10mg of Merck Sharp & Dohme Corp.

Glenmark slips 2% on recall of anti-asthma drug in US

Glenmark Pharma shares declined more than 2 percent on Tuesday morning as the company's recall of its anti-asthma drug from the US market got the street nervous.

Dr Reddy launches Montelukast sodium tablets in US market

Dr Reddy's Laboratories today announced that it has launched Montelukast sodium tablets and Montelukast sodium chewable tablets in US market on Monday.

Aurobindo gets USFDA nod for asthma drug

Aurobindo Pharma today said it has received the final approval from USFDA to manufacture and market montelukast sodium tablets used for treating asthma and allergies.

Glenmark, Aurobindo get US nod for asthma treatment drug

Glenmark Pharmaceuticals' US generics drugs subsidiary has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma.

Glenmark gets tentative US FDA nod for asthma drug

Glenmark Generics Inc USA has received tentative approval from US Food and Drugs Administration for Montelukast Sodium 10 mg tablets, a generic version of pharma major Merck's Singulair tablets.